Resolution of inverse agonist-induced up-regulation from constitutive activity of mutants of the α(1b)-adrenoceptor

Molecular Pharmacology

Volumn 58, Issue 2, 2000, Pages 438-448

  Stevens, Patricia A ^a   Bevan, Nicola ^b   Rees, Stephen ^b   Milligan, Graeme ^a,c  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

^b GLAXOSMITHKLINE   (United Kingdom)

^c UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; ALPHA 1B ADRENERGIC RECEPTOR;

ARTICLE; DRUG RECEPTOR BINDING; GENE MUTATION; HAMSTER; HUMAN; HUMAN CELL; LIGAND BINDING; POINT MUTATION; PRIORITY JOURNAL;

EID: 0033934849     PISSN: 0026895X     EISSN: None     Source Type: Journal    
DOI: 10.1124/mol.58.2.438     Document Type: Article

References (27)

1. 1b-adrenoceptor with green fluorescent protein. Mol Endocrinol 12: 1099-1111.
2. 1-adrenoceptors by fluorescent binding and image analysis reveals identical binding properties of clustered and diffuse populations of receptors. J Pharmacol Exp Ther 268:984-990.
3. 1B-adrenergic receptor. J Biol Chem 272: 28712-28719.
4. Drmota T, Gould GW and Milligan G (1998) Real time visualization of agonist-mediated redistribution and internalization of a green fluorescent protein-tagged form of the thyrotropin-releasing hormone receptor. J Biol Chem 273:24000-24008.
5. 3H] TRH and C-terminal truncations of the long isoform of the rat thyrotropin-releasing hormone receptor-1. Biochem J 346:711-718.
6. Gether U, Ballesteros JA, Seifert R, Sanders-Bush E, Weinstein H and Kobilka BK (1997) Structural instability of a constitutively active G protein-coupled receptor. Agonist-independent activation due to conformational flexibility. J Biol Chem 272:2587-2590.
7. Holtback U, Brismar H, DiBona GF, Fu M, Greengard P and Aperia A (1999) Receptor recruitment: A mechanism for interactions between G protein-coupled receptors. Proc Natl Acad Sci USA 96:7271-7275.
8. Hwa J, Gaivin R, Porter JE and Perez DM (1997) Synergism of constitutive activity in alpha 1-adrenergic receptor activation. Biochemistry 36:633-639
9. Lee TW, Cotecchia S and Milligan G (1997) Up-regulation of the levels of expression and function of a constitutively active mutant of the hamster alpha1B-adrenoceptor by ligands that act as inverse agonists. Biochem J 325:733-739.
10. Lefkowitz RJ, Cotecchia S, Samama P and Costa T (1993) Constitutive activity of receptors coupled to guanine-nucleotide regulatory proteins. Trends Pharmacol Sci 14:303-307.
11. Leurs R, Smit MJ, Alewijnse AE and Timmerman H (1998) Agonist-independent regulation of constitutively active G-protein-coupled receptors. Trends Biochem Sci 23:418-422.
12. 2-adrenoceptor in transfected neuroblastoma x glioma hybrid cells. Mol Pharmacol 50:1479-1486.
13. 2-adrenoceptor-green fluorescent protein fusion proteins. Mol Pharmacol 56:1182-1191.
14. Mhaouty-Kodja S, Barak LS, Scheer A, Abuin L, Diviani D, Caron MG and Cotecchia S (1999) Constitutively active alpha-1b adrenergic receptor mutants display different phosphorylation and internalization features. Mol Pharmacol 55:339-347.
15. Milligan G (1999) Exploring the dynamics of regulation of G protein-coupled receptors using green fluorescent protein. Br J Pharmacol 128:501-510.
16. Milligan G and Bond RA (1997) Inverse agonism and the regulation of receptor number. Trends Pharmacol Sci 18:468-474.
17. Milligan G, Bond RA and Lee M (1995) Inverse agonism: Pharmacological curiosity or potential therapeutic strategy? Trends Pharmacol Sci 16:10-13.
18. Pauwels PJ and Wurch T (1998) Review: Amino acid domains involved in constitutive activation of G-protein-coupled receptors. Mol Neurobiol 17:109-135.
19. Perez DM, Hwa J, Gaivin R, Mathur M, Brown F and Graham RM (1996) Constitutive activation of a single effector pathway: Evidence for multiple activation states of a G protein-coupled receptor. Mol Pharmacol 49:112-122.
20. Rossier O, Abuin L, Fanelli F, Leonardi A and Cotecchia S (1999) Inverse agonism and neutral antagonism at alpha(1a)- and alpha(1b)-adrenergic receptor subtypes. Mol Pharmacol 56:858-866.
21. 2-adrenergic receptor: Extending the ternary complex model. J Biol Chem 268:4625-4636.
22. 1b-adrenergic receptor: Effects on receptor isomerization and activation. Mol Pharmacol 57:219-231
23. Scheer A and Cotecchia S (1997) Constitutively active G protein-coupled receptors: Potential mechanisms of receptor activation. J Recept Signal Transduct Res 17: 57-73.
24. Scheer A, Fanelli F, Costa T, De Benedetti PG and Cotecchia S (1996) Constitutively active mutants of the alpha 1B-adrenergic receptor: Role of highly conserved polar amino acids in receptor activation. EMBO J 15:3566-3578.
25. Scheer A, Fanelli F, Costa T, De Benedetti PG and Cotecchia S (1997) The activation process of the alpha1B-adrenergic receptor: Potential role of protonation and hydrophobicity of a highly conserved aspartate. Proc Natl Acad Sci USA 94:808-813
26. Tsujimoto G, Hirasawa A, Sugawara T and Awaji T (1998) Subtype-specific differences in subcellular localization and chlorethylclonidine inactivation of α1-adrenoceptors. Life Sci 62:1567-1571.
27. Zernicka-Goetz M, Pines J, McLean Hunter S, Dixon JPC, Siemering K, Haseloff J and Evans MJ (1997) Following cell fate in the living mouse embryo. Development 124:1133-1137.